• Je něco špatně v tomto záznamu ?

Influence of early life status epilepticus on the developmental expression profile of the GluA2 subunit of AMPA receptors

E. Szczurowska, P. Ergang, H. Kubová, R. Druga, M. Salaj, P. Mareš,

. 2016 ; 283 (Pt A) : 97-109. [pub] 20160607

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023917

AMPA receptors (AMPARs) are responsible for fast excitatory neurotransmission, and their prolonged activation can result in the generation and spread of epileptic seizures. At early stages of postnatal development, the majority of AMPARs are permeable to both Na(+) and Ca(2+) ions. This permeability, which increases neuronal excitability, is due to the lack of the GluA2 subunit, encoded by the GRIA2A gene, and/or the presence of an unedited GluA2 subunit Q/R site (glutamine instead of arginine). Lithium chloride- and pilocarpine-induced status epilepticus (LiCl/Pilo-SE) in rodents represents a model of severe seizures that result in development of temporal lobe epilepsy (TLE). The aim of this study was to determine how LiCl/Pilo-SE induced early in life (at postnatal day 12; P12) alters normal expression of the GRIA2A gene and GluA2 protein. SE was interrupted by an injection of paraldehyde (Para). Control groups were 1) naïve animals, and 2) siblings of SE rats receiving only LiCl and paraldehyde (LiCl/Para). The expression profile of GRIA2A mRNA was determined via qPCR, and GluA2 protein levels were measured by western blotting. The analysis was performed at 3h (protein levels), and then 3-, 6-, 13-, and 60days, following LiCl/Pilo-SE or LiCl/Para injection (i.e. at P12, P15, P18, P25, P72 respectively). Six different brain regions were analyzed: frontal (CXFR), parietal (CXPAR), and occipital (CXOC) cortex, dorsal (HD) and ventral (HV) hippocampus, and thalamus (TH). There was a significant increase in GRIA2A mRNA expression in the CXFR, CXPAR, and CXOC of P18 SE animals. In CXFR and HD, increased expression of GluA2 AMPAR subunit protein was detected, as well as a surge in GRIA2A mRNA and GluA2 protein expression especially at P18. In HD the surge was detected not only during development (P18), but also later in life (P72). Since high levels of GluA2 can be neuroprotective (by decreasing Ca(2+) permeability), our data suggest that the neocortex and dorsal hippocampus are able to activate endogenous antiepileptic mechanisms. A marked decrease in the overall expression of GluA2 protein in the HV in the LiCl/Pilo-SE and LiCl/Para rats, suggests that the HV is predisposed to excitotoxicity, not only during development, but even in adulthood. Interestingly, LiCl in combination with paraldehyde can also strongly alter the normal ontogeny of GRIA2A mRNA as well as GluA2 subunit protein expression.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023917
003      
CZ-PrNML
005      
20170831115712.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.expneurol.2016.05.039 $2 doi
035    __
$a (PubMed)27288240
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Szczurowska, E $u Department of Developmental Epileptology, Institute of Physiology CAS, Vídeňská 1083, 124 20 Prague 4, Czech Republic; National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic. Electronic address: ewa.szczurowska@epilepsy.biomed.cas.cz.
245    10
$a Influence of early life status epilepticus on the developmental expression profile of the GluA2 subunit of AMPA receptors / $c E. Szczurowska, P. Ergang, H. Kubová, R. Druga, M. Salaj, P. Mareš,
520    9_
$a AMPA receptors (AMPARs) are responsible for fast excitatory neurotransmission, and their prolonged activation can result in the generation and spread of epileptic seizures. At early stages of postnatal development, the majority of AMPARs are permeable to both Na(+) and Ca(2+) ions. This permeability, which increases neuronal excitability, is due to the lack of the GluA2 subunit, encoded by the GRIA2A gene, and/or the presence of an unedited GluA2 subunit Q/R site (glutamine instead of arginine). Lithium chloride- and pilocarpine-induced status epilepticus (LiCl/Pilo-SE) in rodents represents a model of severe seizures that result in development of temporal lobe epilepsy (TLE). The aim of this study was to determine how LiCl/Pilo-SE induced early in life (at postnatal day 12; P12) alters normal expression of the GRIA2A gene and GluA2 protein. SE was interrupted by an injection of paraldehyde (Para). Control groups were 1) naïve animals, and 2) siblings of SE rats receiving only LiCl and paraldehyde (LiCl/Para). The expression profile of GRIA2A mRNA was determined via qPCR, and GluA2 protein levels were measured by western blotting. The analysis was performed at 3h (protein levels), and then 3-, 6-, 13-, and 60days, following LiCl/Pilo-SE or LiCl/Para injection (i.e. at P12, P15, P18, P25, P72 respectively). Six different brain regions were analyzed: frontal (CXFR), parietal (CXPAR), and occipital (CXOC) cortex, dorsal (HD) and ventral (HV) hippocampus, and thalamus (TH). There was a significant increase in GRIA2A mRNA expression in the CXFR, CXPAR, and CXOC of P18 SE animals. In CXFR and HD, increased expression of GluA2 AMPAR subunit protein was detected, as well as a surge in GRIA2A mRNA and GluA2 protein expression especially at P18. In HD the surge was detected not only during development (P18), but also later in life (P72). Since high levels of GluA2 can be neuroprotective (by decreasing Ca(2+) permeability), our data suggest that the neocortex and dorsal hippocampus are able to activate endogenous antiepileptic mechanisms. A marked decrease in the overall expression of GluA2 protein in the HV in the LiCl/Pilo-SE and LiCl/Para rats, suggests that the HV is predisposed to excitotoxicity, not only during development, but even in adulthood. Interestingly, LiCl in combination with paraldehyde can also strongly alter the normal ontogeny of GRIA2A mRNA as well as GluA2 subunit protein expression.
650    _2
$a věkové faktory $7 D000367
650    _2
$a zvířata $7 D000818
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a mozek $x účinky léků $x růst a vývoj $x metabolismus $7 D001921
650    _2
$a konvulziva $x toxicita $7 D003292
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a fluoresceiny $x farmakokinetika $7 D005452
650    _2
$a vývojová regulace genové exprese $x účinky léků $x fyziologie $7 D018507
650    _2
$a chlorid lithný $x toxicita $7 D018021
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pilokarpin $x toxicita $7 D010862
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a AMPA receptory $x genetika $x metabolismus $7 D018091
650    _2
$a status epilepticus $x chemicky indukované $x metabolismus $x patologie $7 D013226
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ergang, P $u Department of Epithelial Physiology, Institute of Physiology CAS, Vídeňská 1083, 124 20 Prague 4, Czech Republic.
700    1_
$a Kubová, H $u Department of Developmental Epileptology, Institute of Physiology CAS, Vídeňská 1083, 124 20 Prague 4, Czech Republic.
700    1_
$a Druga, R $u Department of Developmental Epileptology, Institute of Physiology CAS, Vídeňská 1083, 124 20 Prague 4, Czech Republic; Institute of Anatomy, Second Faculty of Medicine, Charles University, U nemocnice 3, 128 00 Prague, Czech Republic.
700    1_
$a Salaj, M $u Institute of Anatomy, Second Faculty of Medicine, Charles University, U nemocnice 3, 128 00 Prague, Czech Republic.
700    1_
$a Mareš, P $u Department of Developmental Epileptology, Institute of Physiology CAS, Vídeňská 1083, 124 20 Prague 4, Czech Republic.
773    0_
$w MED00001749 $t Experimental neurology $x 1090-2430 $g Roč. 283, č. Pt A (2016), s. 97-109
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27288240 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170831120302 $b ABA008
999    __
$a ok $b bmc $g 1239598 $s 984830
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 283 $c Pt A $d 97-109 $e 20160607 $i 1090-2430 $m Experimental neurology $n Exp Neurol $x MED00001749
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...